Provided by Tiger Trade Technology Pte. Ltd.

Celcuity Inc

79.52
+2.142.77%
Post-market: 79.520.00000.00%19:46 EDT
Volume:2.56M
Turnover:206.25M
Market Cap:3.88B
PE:-18.40
High:88.68
Open:81.30
Low:77.84
Close:77.38
52wk High:151.02
52wk Low:44.42
Shares:48.77M
Float Shares:29.72M
Volume Ratio:2.86
T/O Rate:8.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3223
EPS(LYR):-3.7900
ROE:-1433.70%
ROA:-25.78%
PB:-303.41
PE(LYR):-20.98

Loading ...

Celcuity Price Target Cut to $134.00/Share from $140.00 by Needham

Dow Jones
·
Yesterday

Celcuity Inc. : Leerink Partners Cuts Target Price to $147.00 from $148.00

THOMSON REUTERS
·
Yesterday

Celcuity Gains as Breast Cancer Drug Launches in US

Reuters
·
Yesterday

Celcuity - Announces Revtorpyk NOW Commercially Available in the United States

THOMSON REUTERS
·
Yesterday

Celcuity Gains; J.P.Morgan Initiates Coverage with 'overweight'

Reuters
·
Sep 17

U.S. Research Roundup-Celcuity, Fluence Energy, Salesforce

Reuters
·
Sep 17

County Leader Inspects Progress on Key Construction Initiatives

Deep News
·
Sep 10

Celcuity submits Revtorpyk sNDA to the FDA

TIPRANKS
·
Aug 26

Celcuity Submits FDA sNDA for Revtorpyk in Pik3ca-Mutant Advanced Breast Cancer

Reuters
·
Aug 26

Celcuity Submits Snda to FDA for Revtorpyk™ (Gedatolisib) for Hr+/Her2-, Pik3CA Mutant Locally Advanced or Metastatic Breast Cancer

THOMSON REUTERS
·
Aug 26

Craig-Hallum Sticks to Its Buy Rating for Celcuity (CELC)

TIPRANKS
·
Aug 18

Celcuity Price Target Maintained with a $177.00/Share by Citizens

Dow Jones
·
Aug 17

Celcuity price target raised to $175 from $165 at Guggenheim

TIPRANKS
·
Aug 17

The Bull Case For Celcuity (CELC) Could Change Following Revtopik’s FDA Approval And NCCN Category 1 Status

Simply Wall St.
·
Aug 16

VistaGen Q1 Revenue Rises on Licensing Agreement Expiration

Reuters
·
Aug 14

Stifel Nicolaus Reaffirms Their Buy Rating on Celcuity (CELC)

TIPRANKS
·
Aug 14

Wells Fargo Reaffirms Their Buy Rating on Celcuity (CELC)

TIPRANKS
·
Aug 14

Celcuity Price Target Cut to $140.00/Share from $157.00 by Needham

Dow Jones
·
Aug 14

U.S. Research Roundup-Cisco, Fox Corp, Target

Reuters
·
Aug 14

Celcuity Inc. : Jefferies Raises Target Price to $163 from $153

THOMSON REUTERS
·
Aug 14